Reappraisal of the options for colorectal cancer screening in England

Colorectal Disease

Volumn 14, Issue 9, 2012, Pages

  Whyte, S ^a   Chilcott, J ^a   Halloran, S ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Colorectal cancer; Economic model; Faecal occult blood test; Flexible sigmoidoscopy; Screening

Indexed keywords

ARTICLE; CALIBRATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COHORT ANALYSIS; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; IMMUNOCHEMISTRY; INTESTINE ENDOSCOPY; OCCULT BLOOD TEST; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PROCESS MODEL; RECTUM MUCOSA; SIGMOIDOSCOPY; UNITED KINGDOM;

AGED; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; ENGLAND; HUMANS; MIDDLE AGED; MODELS, ECONOMIC; OCCULT BLOOD; PRACTICE GUIDELINES AS TOPIC; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

EID: 84865404456     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03014.x     Document Type: Article

References (26)

1. Cancer Research UK. (2010) UK Cancer Incidence and Mortality Summary, June 2010.
2. Tappenden P, Eggington S, Nixon R et al. (2004) Colorectal Cancer Screening Options Appraisal. Report to the English Bowel Cancer Screening Working Group.
3. Tappenden P, Chilcott J, Eggington S et al. Option appraisal of population-based colorectal cancer screening programmes in England. Gut 2007; 56: 677-84.
4. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624-33.
5. Logan R, Patnick J, Coleman L, Nickerson C. (2010) Outcomes of the Bowel Cancer Screening Programme in England After the First 1 Million Tests. A18.
6. Zorzi M, Fedato C, Naldoni C et al. Screening for colorectal cancer in Italy: 2007 survey. Epidemiol Prev 2009; 33(3 Suppl 2): 57-74.
7. Brenner H, Altenhofen L, Hoffmeister M. Sex, age, and birth cohort effects in colorectal neoplasms: a cohort analysis. Ann Intern Med 2010; 152: 697-703.
8. Whyte S, Walsh C, Chilcott J. Bayesian calibration of a natural history model with application to a population model for colorectal cancer. Med Decis Making 2011; 31: 625-41.
9. National Institute for Health and Clinical Excellence. (2008) Updated Guide to the Methods of Technology Appraisal - June 2008. National Institute for Health and Clinical Excellence, London.
10. Tappenden P. (2011) A methodological framework for developing whole disease models to inform resource allocation decisions: an application in colorectal cancer. PhD Thesis, University of Sheffield.
11. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51(Suppl 5): V6-9.
12. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-89.
13. Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog 1996; 7: 293-342.
14. Brenner H, Hoffmeister M, Stegmaier C et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840, 149 screening colonoscopies. Gut 2007; 56: 1585-9.
15. Office of National Statistics. (2010) Interim Life Tables 2007-09.
16. Northern and Yorkshire Cancer Registry and Information Service and the National Cancer Intelligence Network, Aravani A TJDM&ME. (2009) Incidence data and relative survival rates calculated from the National Cancer Data Repository.
17. Castiglione G, Grazzini G, Miccinesi G et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002; 9: 99-103.
18. Martinez ME, Baron JA, Lieberman DA et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009; 136: 832-41.
19. Whyte S, Chilcott J, Essat M et al. (2011) Reappraisal of the Options for colorectal Cancer Screening. http://www.screening.nhs.uk/policydb_download.php?doc=130 (accessed December 2010).
20. Chib S, Greenberg E. Understanding the Metropolis-Hastings algorithm. Am Stat 1995; 49: 327-35.
21. Cooper K, Squires H, Carroll C et al. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess 2010; 14: 1-206.
22. Ara R, Brazier JE. (2010) Using health state utility values from the general population to approximate baselines in decision analytic models when condition specific data are not available.
23. Nickerson C. (2010) Data received from NHS Bowel Cancer Screening Programme.
24. Zorzi MRTDV. (2010) Italian iFOBT screening programme data.
25. Atkin WS. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291-300.
26. Chung SJ, Kim YS, Yang SY et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. J Gastroenterol Hepatol 2010; 25: 519-25.